Effect of Clinical Trials on Survival After Heart Transplantation

Transplantation Proceedings

Volumn 40, Issue 9, 2008, Pages 3044-3045

  Sanchez Lazaro I J ^a   Almenar Bonet, L ^a   Martinez Dolz L ^a   Moro Lopez J ^b   Ortiz Martinez V ^a   Sanchez Soriano R ^a   Sanchez Gomez J M ^a   Cano, O ^a   Salvador, Antonio ^a  

^a Heart Failure and Transplant Unit   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INOTROPIC AGENT;

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART TRANSPLANTATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STUDENT T TEST; SURVIVAL;

CLINICAL TRIALS AS TOPIC; EMERGENCIES; HEART TRANSPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; PATIENT SELECTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; SURVIVORS;

EID: 55749105868     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.08.113     Document Type: Article

References (3)

1. Arnau de Bolós J.M., and Brotons Cuixart C. The continuity between the clinical investigation and the daily practice. Investigational Clinical Guide for Primary Care (2005), Ediciones Mayo SA, Barcelona, Spain
2. Rosser W. Application of evidence from randomised controlled trials to general practice. Lancet 353 (1999) 661
3. Peralta V. Clinical trials, pharmaceutical companies and clinical practice. Ann Nealth Syst Navarre 28 (2005) 1